On March 14, 2016, Nuvectra Corporation completed its spin-off from Greatbatch, Inc. into an independent, publicly-traded neurostimulation medical device company. The company is headquartered in Plano, Texas, with additional locations in Denver, Ann Arbor, and Minneapolis.
Nuvectra currently trades on the NASDAQ Global Market (NASDAQ) under the ticker symbol "NVTR."
Data provided by Nasdaq. Minimum 15 minutes delayed.
February 28, 2019
Nuvectra® Reports Fourth Quarter and Full Year 2018 Financial Results
Record Fourth Quarter & Full Year 2018 Algovita® Sales of $14.1 million and $47.1 million, Up 36% and 84% YoY Respectively PLANO, Texas, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the fourth quarter and full year ended December 31, 2018. Recent Highlights Record consolidated revenues of $14.5 million and $48.8 million in the fourth quarter and full year 2018, up 36% an
February 26, 2019
Nuvectra® to Present at 39th Annual Cowen Healthcare Conference
PLANO, Texas, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Fred Parks, PhD, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at the upcoming 39th Annual Cowen Healthcare Conference in Boston, Massachusetts. Event: 39th Annual Cowen Healthcare Conference Date: Tuesday, March 12, 2019 Time:
The Ruth Group
|There are currently no events scheduled.|